AviadoBio, a pioneering gene therapy company dedicated to developing and delivering potentially transformative medicines for neurodegenerative disorders, today announced that the company has initiated ...
LONDON, March 31, 2026--(BUSINESS WIRE)--AviadoBio, a pioneering gene therapy company dedicated to developing and delivering potentially transformative medicines for neurodegenerative disorders, today ...
ZURICH--(BUSINESS WIRE)--AL-S Pharma AG, a clinical-stage biotechnology company discovering and developing human antibodies that target misfolded proteins implicated in amyotrophic lateral sclerosis ...
Preparations underway to advance AP-101 into confirmatory Phase 3 clinical trial with initiation aimed for late 2026 ZURICH, March 19, 2026--(BUSINESS WIRE)--AL-S Pharma AG, a clinical-stage ...
BREVARD COUNTY, Fla. — Endeavour Elementary students will perform “101 Dalmatians KIDS” on Thursday at the Rockledge High School Auditorium. The event marks the culmination of a unique partnership ...
The MarketWatch News Department was not involved in the creation of this content. MORRISTOWN, N.J., March 10, 2026 (GLOBE NEWSWIRE) -- Piston Bio LLC, a clinical-stage biotechnology company developing ...
MORRISTOWN, N.J., March 10, 2026 (GLOBE NEWSWIRE) -- Piston Bio LLC, a clinical-stage biotechnology company developing therapeutics targeting neuroimmune mechanisms in cancer, today announced the ...
ZURICH, Switzerland, March 9, 2026 /PRNewswire/ -- NewcelX Ltd. (NCEL), a clinical-stage company advancing stem-cell-derived therapies for Type 1 Diabetes, today announced a collaborative research ...
Tufts is piloting a new pre-college program this summer called College Prep 101 for Neurodivergent Students, designed to help neurodivergent high school students prepare for their transition to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results